MPS Pharmaa

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE537C01019
  • NSEID:
  • BSEID: 531686
INR
1.85
-0.23 (-11.06%)
BSENSE

Dec 29

BSE+NSE Vol: 1.25 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About MPS Pharmaa Ltd stock-summary
stock-summary
MPS Pharmaa Ltd
Small Cap
Pharmaceuticals & Biotechnology
Advik Laboratories Ltd has been set up from the ground level with the avowed objective of achieving USFDA standards of quality. The product range includes ethical i.e. Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin and Chewfe-C., generic drugs i.e. antibacterials, antiallergics, antifungals, analgesic, antipyretic and anti-inflammatory, anti-hypertensives, anthelminthics, anti-malarials, corticosteroids, erectile dysfunction, gastrointestinal agents and sedatives. and over the counter drugs (OTC) in various formulations.
Company Coordinates stock-summary
Company Details
138 Roz-Ka-Meo Industrial Area, Sohna Mewat Haryana : 122103
stock-summary
Tel: 91-124-2362471/2014471
stock-summary
mail@advikindia.com
Registrar Details
MAS Services Ltd, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 19.11 Cr
Number of Shares
1.91 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
15-May-2015
1.91
19.11
4082650
10
Conversion of Warrants
15-May-2015
1.91
19.11
4082650
10
Conversion of Warrants
21-Nov-2013
1.5
15.03
5675350
10
Conversion of Warrants
21-Nov-2013
1.5
15.03
5675350
10
Conversion of Warrants
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

16.0362

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Omkam Pharmaceuticals Private Limited (25.65%)

Highest Public shareholder

Pataliputra International Limited (17.51%)

Individual Investors Holdings

37.07%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Peeyush Kumar Aggarwal
Managing Director
0
Manoj Kumar Jain
Independent Director
0
Pooja Chuni
Company Secretary
2.91 lacs
Madhu Sharma
Independent Director
0
Ram Niwas Sharma
Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Active Raw Materials
212540000
0%
 
100
Active Raw Materials
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenue - Income from Jobwork
0.10
2.34%
 
2.34
Other Operating Revenue - Income from Jobwork
97.66
Other Operating Revenue - Income from Jobwork
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 4 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

30

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

6.90

stock-summary
Return on Equity

-83.28%

stock-summary
Price to Book

3.68